MedPageToday - September 22, 2023
Jill Crandall, M.D., a member of the FDA's Endocrinologic and Metabolic Drugs Advisory Committee, explains that she voted against approving an implant device for type 2 diabetes in part because patient data weren't consistent regarding the device's delivery of a GLP-1 agonist drug. Dr. Crandall is professor of medicine and the Jacob A. and Jeanne E. Barkey Chair in Medicine at Einstein, and chief of endocrinology at Einstein and Montefiore.
Dr. Crandall's ProfileMore coverage on Dr. Crandall
NPR - September 21, 2023
Jonathan Alpert, M.D., Ph.D., says patients using drugs like Ozempic and Wegovy, commonly prescribed for diabetes, should talk to their doctors about any mental health issues they may be experiencing while taking the medications. Dr. Alpert is the Dorothy and Marty Silverman Chair in Psychiatry at Einstein and is chair and professor of psychiatry and behavioral sciences at Einstein and Montefiore.
Dr. Alpert's ProfileMore coverage on Dr. Alpert
The Philadelphia Inquirer - August 24, 2023
Sofiya Milman, M.D., M.S., describes the SuperAgers Family Study, which seeks to discover drivers of healthy longevity in people over the age of 95. Dr. Milman is associate professor of medicine and of genetics and director of Human Longevity Studies at Einstein’s Institute for Aging Research and an endocrinologist at Montefiore.
Additional coverage includes CNBC and Fox32 Chicago
Dr. Milman's ProfileMore coverage on Dr. Milman
Leaders - August 19, 2023
Lynne Holden, M.D., discusses Einstein’s longstanding commitment to diversity and inclusion and her own background mentoring students in medicine. Dr. Holden is professor of emergency medicine and senior associate dean for diversity and inclusion at Einstein and an emergency medicine physician at Montefiore.
Dr. Holden's ProfileMore coverage on Dr. Holden
The New York Times - August 10, 2023
John Greally, M.D., Ph.D., D.Med., says he remains skeptical about the value of so-called epigenetic clocks, which estimate an organism's age by analyzing chemical tags on its DNA. Dr. Greally is director of the Center for Epigenomics, professor of genetics and of pediatrics, and chief of the division of genomics at Einstein, and a pediatric geneticist at Children’s Hospital at Montefiore.
Dr. Greally's ProfileMore coverage on Dr. Greally
The New York Times - July 27, 2023
Nir Barzilai, M.D., describes his research on genetic mutations that may slow the effects of aging. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Additional coverage includes CNN
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
MedPageToday - July 22, 2023
Karen Bonuck, Ph.D., describes the devastating impacts of long COVID and advises healthcare professionals to educate themselves on diagnosis and treatment and to advocate for legislation that will benefit patients. Dr. Bonuck is professor of family and social medicine, of obstetrics & gynecology and women's health, and of pediatrics at Einstein and co-director of the Rose F. Kennedy University Center of Excellence in Developmental Disabilities at Einstein and Montefiore.
Dr. Bonuck's ProfileMore coverage on Dr. Bonuck
BronxNetOpen - July 19, 2023
Jennifer Hardell, an Einstein medical student, explains her recent research that found air pollution is associated with longer hospital stays for children with asthma.
CBS News - July 19, 2023
Simon Rego, Psy.D., says that recharging and refreshing can be helpful for mental health, but it's important to be mindful to avoid spending too much time in bed, a viral trend known as "bed rotting." Dr. Rego is professor of psychiatry and behavioral sciences, chief of psychology, and director of psychology training at Einstein and Montefiore.
Dr. Rego's ProfileMore coverage on Dr. Rego
Science News - June 30, 2023
Johanna Daily, M.D., M.S., discusses the current outbreak of malaria in Texas and Florida and says the risk of transmission is low and the disease is preventable and curable. Dr. Daily is professor of medicine and of microbiology & immunology at Einstein and an infectious disease physician at Montefiore.
Additional coverage includes Fox News and WIRED
Dr. Daily's ProfileMore coverage on Dr. Daily
STAT News - June 22, 2023
Shivani Agarwal, M.D., M.P.H., discusses a series in The Lancet, which she led, that described the exponential growth of diabetes globally, driven by structural racism and geographic inequities, and outlines action plans to address the issue. Dr. Agarwal is associate professor of medicine and associate director of the Fleischer Institute for Diabetes and Metabolism at Einstein and an endocrinologist at Montefiore.
Additional coverage includes The Mirror, The Guardian, Independent, Al Jazeera, and CNN Brazil (requires translation) and New York Post
Dr. Agarwal's ProfileMore coverage on Dr. Agarwal
New York Social Diary - June 15, 2023
Marla Keller, M.D., was among the honorees at the 68th Spirit of Achievement Awards Luncheon hosted by the Women's Division of Albert Einstein College of Medicine. Dr. Keller is director of the Harold and Muriel Block Institute for Clinical and Translational Research, and professor and vice chair of medicine at Einstein and Montefiore.
Dr. Keller's ProfileMore coverage on Dr. Keller
Medscape - June 15, 2023
Vilma Gabbay, M.D., comments on a study that suggests patients with persistent depressive or cognitive symptoms after COVID-19 may have gliosis, a condition that occurs when the body creates more or larger glial cells, which support nerve cells. Dr. Gabbay is professor of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein and is also the director of the Psychiatry Research Institute at Montefiore Einstein (PRIME) Center for Biomarkers and Dimensional Psychiatry.
Dr. Gabbay's ProfileMore coverage on Dr. Gabbay